Candel Therapeutics, Inc.
CADL • NASDAQ • Stock Fundamentals
Candel Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul-Peter Tak, with a market cap of $585.4M.
Market Cap$585.4M
Employees42.0
CEOPaul-Peter Tak
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 3 monthsQ2 2026
Financials
Based on Q1 2026 filing
Candel Therapeutics, Inc. FAQ
Common questions about Candel Therapeutics, Inc.
Candel Therapeutics, Inc. (CADL) has a market capitalization of $585.4M and trades on NASDAQ.
Candel Therapeutics, Inc. has approximately 42 employees.